Cargando…
Targeted Therapies in the Treatment of Advanced Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most common liver cancer and the third leading cause of cancer death. It has been a major worldwide health problem with more new cases being diagnosed each year. The current available therapies for patients with advanced HCC are extremely limited. Therefore, it...
Autores principales: | Wei, Zhengyu, Doria, Cataldo, Liu, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667684/ https://www.ncbi.nlm.nih.gov/pubmed/23761989 http://dx.doi.org/10.4137/CMO.S7633 |
Ejemplares similares
-
Combination treatment including targeted therapy for advanced hepatocellular carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2016) -
Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma
por: Tazi, El Mehdi, et al.
Publicado: (2011) -
Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma
por: Carloni, Riccardo, et al.
Publicado: (2023) -
Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
por: Liu, Ziyu, et al.
Publicado: (2019) -
The advanced development of molecular targeted therapy for hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2022)